A 43-year-old white male was referred to the Emergency Department with acute onset of severe dyspnea, cyanosis, and dry cough. He previously underwent a left-foot amputation in 2011 for synovial-sarcoma. In 2012, the patient experienced a relapse with bilateral lung metastases (Fig 1) and, two months before admission, he started Pazopanib (Votrient, Glaxo Group Ltd, Brentford, UK) treatment. On day 72, a chest X-ray (Fig 2) revealed a large right spontaneous pneumothorax (PNX) simultaneously associated to a left one. Thus, a 24 Fr chest tube was placed on each side providing immediate improvement of his clinical condition (Fig 3) . No signs of air leakage were discovered during hospitalization; therefore, the patient was discharged on the sixth postoperative day without consequence. Four days after discharge, he experienced a sudden swelling of the chest wall and moderate dyspnea. A chest computed tomography scan revealed a massive pneumomediastinum associated to large subcutaneous emphysema of the chest wall soft tissues (Fig 4) . After the second admission, a multidisciplinary meeting was performed and Pazopanib administration was ceased. His hospital course was unremarkable and seven days later he was discharged after regression of symptoms and complete radiological resolution.
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Simultaneous bilateral spontaneous PNX represents 0.9-4.0% of all spontaneous PNX; 1 moreover, PNX secondary to lung metastases is not commonly reported in literature. Although angiogenesis-inhibitor therapy (AIT) is known to cause tumor cavitation and "therapeutic erosion" of lung metastases, 2 PNX incidence was rarely reported in AIT clinical trials. 3, 4 Bilateral spontaneous PNX (Fig 2) immediately treat (by chest tube insertion and respiratory care, Fig 3) during follow-up of metastatic patients under Pazopanib. Contrary to reports by other scholars, 4 an association with pneumomediastinum (Fig 4) caused by an erosion of lung metastases closer to the mediastinum is even rarer; when this condition occurs, a multidisciplinary evaluation (with oncologist, pneumologist, and thoracic surgeon) is required in order to undertake a conservative treatment (and the ceasing of drug administration).
In conclusion, although it rarely occurs, the onset of an air leak (PNX or pneumomediastinum) during Pazopanib treatment is a life-threatening condition related to lung metastases erosion. Thus, a close clinico-radiological examination is mandatory in pulmonary metastatic patients under AIT.
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Figure 4
Chest computed tomography (CT) scan revealed a massive pneumomediastinum associated to a large subcutaneous emphysema of the chest wall soft tissues.
